| |
| |
|
| Insider
Information: |
Loury David J |
| Relationship: |
Executive VP, Toxicology |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,628 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,628 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmacyclics Inc |
PCYC |
Executive VP, Toxicology |
2013-10-31 |
1,628 |
2009-10-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCYC |
Pharmacyclics Inc |
Executive VP, Toxicology |
• – – |
2013-10-31 |
4 |
A |
$10.56 |
$12,024 |
D/D |
1,139 |
1,628 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2013-04-30 |
4 |
A |
$10.56 |
$1,731 |
D/D |
164 |
489 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2013-02-05 |
4 |
AS |
$70.58 |
$1,411,510 |
D/D |
(20,000) |
325 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2013-02-05 |
4 |
OE |
$2.76 |
$55,200 |
D/D |
20,000 |
20,325 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2013-01-09 |
4 |
S |
$66.30 |
$698,205 |
D/D |
(10,531) |
325 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2013-01-09 |
4 |
S |
$4.16 |
$43,809 |
D/D |
(10,531) |
10,856 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2013-01-08 |
4 |
S |
$64.70 |
$647,000 |
D/D |
(10,000) |
325 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2013-01-08 |
4 |
OE |
$4.16 |
$41,600 |
D/D |
10,000 |
10,325 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2012-12-20 |
4 |
S |
$61.12 |
$2,412,274 |
D/D |
(39,469) |
325 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2012-12-20 |
4 |
OE |
$4.16 |
$164,191 |
D/D |
39,469 |
39,794 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2012-10-31 |
4 |
A |
$10.56 |
$1,721 |
D/D |
163 |
325 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2012-04-30 |
4 |
A |
$10.56 |
$1,710 |
D/D |
162 |
29,369 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2011-10-31 |
4 |
A |
$1.61 |
$5,184 |
D/D |
3,227 |
29,207 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2011-04-29 |
4 |
A |
$1.61 |
$16,065 |
D/D |
10,000 |
25,980 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Scientific Officer |
• – – |
2010-10-29 |
4 |
A |
$1.61 |
$16,065 |
D/D |
10,000 |
15,980 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Vice President of Development |
• – – |
2009-10-30 |
4 |
A |
$1.06 |
$1,063 |
D/D |
1,000 |
1,000 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
